June 5, 2023
FDA: Class I recall of specific Abiomed Impella 5.5 with SmartAssist heart pumps
Editor's Note
The Food and Drug Administration (FDA), on June 5, identified the recall by Abiomed of specific Impella 5.5 with SmartAssist heart pumps as Class I, the most serious.
The recall was initiated because of fluid leaking from the purge sidearm of the pump. If the leak issue is not resolved, persistent low purge pressure and purge flow may cause the pump to stop and the loss of support to the pumping chambers of the heart.
The company reports 179 complaints, 3 injuries, and no deaths related to this issue.
The product code is 0550-0008. Distribution dates were September 28, 2021 to March 6, 2023.
Free Daily News
- AI boosts accuracy in surgical reports, outperforming surgeons
- AI models improve prediction of surgical complications using preoperative clinical notes
- Ambient AI healthcare documentation gains traction as capabilities expand
- Healthcare M&A faces tighter review as FTC retains guidelines
- Healthcare giants prioritize shareholder payouts over patient care
- Texas abortion ban linked to spike in pregnancy complications, maternal death
- AI streamlines documentation, frees time for nurses at Cedars-Sinai surgical unit
- Study identifies potential non-surgical treatment for inguinal hernias
- Rural hospital closures remain a growing concern despite slight financial improvement
- Session: Hoisting the Sails—Winning Strategies for Growing Service Lines in an ASC
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement